Literature Review : Pemilihan Terapi pada Pasien Pneumonia Berusia 0-18 Tahun

Authors

  • Dinda Ayu Lestari Universitas Mataram
  • Tuhfatul Ulya Universitas Mataram
  • Steve Pratama Tanjaya Universitas Mataram
  • Faolananda Qurrota A'yun Universitas Mataram
  • Ida Ayu Adriani Maheswari Universitas Mataram
  • Achmad Hidayaturrohman Universitas Mataram
  • Mitha Juliana Mustika Universitas Mataram

DOI:

https://doi.org/10.59024/jikas.v4i2.1735

Keywords:

Antibiotics, Diagnostic testing, Pediatric pneumonia, Pediatrics, Pneumonia treatment

Abstract

Pneumonia is one of the leading causes of morbidity and mortality among children aged 0–18 years worldwide. Appropriate treatment is crucial for improving treatment outcomes and preventing complications and antibiotic resistance. This literature review aims to analyze treatment options for pneumonia in pediatric patients based on articles published in PubMed from 2024 to 2025. The method used involved searching for articles with the keywords “(Case Reports) AND (pneumonia) AND (in children)” using filters for free full text, case reports, English language, human subjects, and the 0–18-year-old age group. Of the 71 articles identified, 10 met the inclusion criteria. The review results indicate that pneumonia treatment in children is dominated by the use of antibiotics and supportive care. In cases of severe pneumonia and necrotizing pneumonia, intensive antimicrobial therapy, close monitoring, and management of complications are required. Modern diagnostic tests such as bronchoalveolar lavage fluid (BALF), rapid syndromic arrays, and metagenomic next-generation sequencing (mNGS) help identify pathogens more quickly and accurately, thereby allowing for more targeted therapy. Additionally, corticosteroids and immunoglobulins are used as adjunctive therapies in cases of severe inflammation. Accurate diagnosis and individualized therapy selection play a crucial role in improving clinical outcomes for pediatric pneumonia patients. 

References

Alebaji, M., Hassan, R., & Saleh, A. (2024). Uncovering the hidden cause of recurrent chest infections in a child: A case report. Clinical Case Reports, 12(9), e9432.

Asseri, A. A., Shati, A. A., Al-Benhassan, I., Jabali, S. H., Alolah, T. A., Albarqi, N. H., & Alqahtani, M. S. (2024). Esophageal achalasia presenting as recurrent pneumonia in children: A case series. Medicine, 103(44), e40402.

Chen, L., & Zhou, Y. (2024). Etiological diagnosis and treatment value of metagenomic next-generation sequencing in children with severe pneumonia: A case report. BMC Pediatrics, 24(1), 214.

Chen, Z., Liu, X., & Wang, Y. (2024). Doxycycline treatment efficacy in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. Italian Journal of Pediatrics, 50(1), 115.

Cheng, R., Wang, Q., Jiang, L., & Liu, L.-M. (2024). Pulmonary thromboembolism due to Mycoplasma pneumoniae in children: A case report and literature review. BMC Pediatrics, 24(1), 816.

Clark, J. A., Peterson, M., & White, R. (2024). Enhanced diagnosis of severe bacterial and fungal respiratory infections in children using rapid syndromic testing: A case report. Frontiers in Cellular and Infection Microbiology, 14, 1380674.

Dharmawan, A., & Layanto, N. (2022). Efektivitas ceftazidime-avibactam terhadap bakteri gram negatif penghasil enzim karbapenemase. Jurnal MedScientiae, 1(1), 40–46.

Ding, Y., Zhang, H., & Li, X. (2024). Necrotizing pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in children: A case report. BMC Infectious Diseases, 24(1), 944.

Fiorini, N., Canese, K., Starchenko, G., Kireev, E., Kim, W., Miller, V., et al. (2018). Best match: New relevance search for PubMed. PLoS Biology, 16(8), e2005343.

GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222.

GBD 2021 Lower Respiratory Infections Collaborators. (2024). Global, regional, and national incidence and mortality burden of non-COVID lower respiratory infections and aetiologies, 1990–2021: A systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases, 24(5), 563–579.

He, J., Zhang, Y., & Li, W. (2024). Application of targeted next-generation sequencing in detecting macrolide-resistant Mycoplasma pneumoniae in pediatric pneumonia. BMC Infectious Diseases, 24(1), 612.

Huang, Z., Chen, Y., & Lin, P. (2024). A Case of Necrotic pneumonia caused by Streptococcus pneumoniae diagnosed using bronchoalveolar lavage fluid in a child: A case report. Medicine, 103(37), e39252.

Insan, N. G., Rahmawati, D., & Sari, P. (2023). Rasionalitas penggunaan antibiotik pada pasien pneumonia anak di rumah sakit. Jurnal Farmasi Klinik Indonesia, 12(2), 95–103.

Jin, P., Han, C., Guo, W., & Xu, Y. (2024). Mycoplasma pneumoniae pneumonia-associated thromboembolism with plastic bronchitis: A series of five case reports and literature review. Italian Journal of Pediatrics, 50(1), 117.

Juwita, D. A., Sari, M., & Wulandari, R. (2017). Evaluasi ketepatan penggunaan antibiotik pada pasien pneumonia pediatrik. Jurnal Ilmiah Farmasi, 13(1), 45–53.

Lau, T. Y., Wong, K. Y., & Chan, E. W. (2024). A child with COVID-19 complicated by severe organizing pneumonia: A case report. Respiratory Medicine Case Reports, 53, 102154.

Lee, J. H., Lee, B. J., Park, C., Song, H., Ock, C. Y., Sung, H., Woo, S., Youn, Y., Jung, K., Jung, J. H., Ahn, J., Kim, B., Kim, J., Seo, J., & Hwang, J. H. (2023). Efficacy improvement in searching MEDLINE database using a novel PubMed visual analytic system: EEEvis. PLOS ONE, 18(3), e0282615.

Li, H., Zhao, X., & Chen, Y. (2024). Clinical characteristics of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children. Frontiers in Pediatrics, 12, 1489389.

Li, Y., Yuan, T., Yang, J., Liu, H., Li, P., & Fu, H. (2024). Successful conservative treatment of necrotizing pneumonia in pediatric patients: Two case reports. Alternative Therapies in Health and Medicine, 30(11), 108–113.

Liu, L., Huang, Y., Shu, S., Zhou, H., Fang, F., & Liu, X. (2024). Nocardia farcinica pneumonia complicated by Pneumocystis jiroveci infection in children with neuromyelitis optica spectrum disorders: A case report and literature review. Italian Journal of Pediatrics, 50(1), 255.

Pereira, V. C., Silvia, S. N., Carvalho, V. K. S., Zanghelini, F., & Barreto, O. M. (2022). Strategies for the implementation of clinical practice guidelines in public health: An overview of systematic reviews. Health Research Policy and Systems, 20(13), 1–21.

Rigustia, R., Zeffira, L., & Vani, A. T. (2019). Faktor risiko berhubungan dengan kejadian pneumonia pada balita di Puskesmas Ikur Koto Kota Padang. Health & Medical Journal, 1(1), 22–29.

Song, Q., Xu, B., & Wang, L. (2024). Alternative antibiotic therapy in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. BMC Infectious Diseases, 24(1), 1007.

Sun, H., Wang, W.-Q., Lin, L., Shao, Z.-Y., Zhan, L., & Tang, L.-F. (2024). Case report: Mycoplasma pneumoniae-associated acute pancreatitis. Frontiers in Pediatrics, 12, 1416189.

Tang, Q., Zhang, H., & Kang, Y. (2025). Children with acute respiratory distress syndrome and refractory pneumonia caused by Mycoplasma pneumoniae. New Microbiologica, 48(1), 78–83.

Tong, L., Huang, S., Zhang, Y., et al. (2022). Refractory Mycoplasma pneumoniae pneumonia in children: Early recognition and management. Journal of Clinical Medicine, 11(10), 2824.

Torres, A., Cilloniz, C., Niederman, M. S., et al. (2021). Pneumonia. Nature Reviews Disease Primers, 7(1), 25.

Veridiana, N. N., Octaviani, & Nurjana, M. A. (2021). Faktor internal dan eksternal kejadian pneumonia pada anak bawah 2 tahun di Indonesia. Buletin Penelitian Kesehatan, 49(3), 145–154.

Waites, K. B., Xiao, L., & Zheng, X. (2024). Emergence of macrolide-resistant Mycoplasma pneumoniae infections in children in the United States. Journal of the Pediatric Infectious Diseases Society. Advance online publication.

Wang, K., & Tu, Y. (2024). Challenges of macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. World Journal of Pediatrics, 20(4), 345–352.

World Health Organization. (2023). Antimicrobial resistance.

Zhang, Y., Li, X., & Chen, H. (2025). Case Report: Necrotizing pneumonia in pediatric patients: a rare case of unilateral necrosis in two entire lobe tissues. Frontiers in Pediatrics, 13, 1458921.

Zhang, H., & Jin, W. (2024). Human immunoglobulin combined with antimicrobial agents in severe pediatric pneumonia: A case report. Medicine, 103(15), e38586.

Downloads

Published

2026-05-31